Build vs buy
Today’s biopharma dilemma: explore viable options that offer fast deployment and flexible, scalable manufacturing capability
Popular resources
Generate biopharma funds
Deliver groundbreaking therapies to patients in need quickly by pursuing the right funding at the right time
A cell thawing guide
The science, research, and methods behind efficient, effective cell therapy thawing
Viral vector production
Strategies for your business model to address the viral vector manufacturing shortage
Developing a biologic drug
Key milestones and planning for compliance when bringing a new biologic drug to market
Coronavirus update
Efforts to address Covid-19 for customers, suppliers, and governments